HH&L Acquisition Co. Merges With DiaCarta to Create a Public Company
October 14, 2022
DiaCarta entered into a definitive business combination agreement with SPAC HH&L Acquisition Co. to become a publicly listed company. The transaction is expected to provide DiaCarta access to approximately $414 million held in HH&L’s IPO trust and is expected to close in the first quarter of 2023.
- Buyers
- HH&L Acquisition Co.
- Targets
- DiaCarta, Ltd, DiaCarta, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
HGP Intelligent Energy to Become Public via Business Combination with Meshflow Acquisition Corp
September 8, 2026
AI & Machine Learning
HGP Intelligent Energy entered into a definitive business combination agreement with Meshflow Acquisition Corp. The transaction will combine the companies under a newly formed Delaware holding company (Leyte Parent, Inc.), resulting in HGP becoming publicly traded. Proceeds are expected to support qualification/manufacturing of HGP’s variable-speed reactor coolant pump, further digital twin development, and work related to the Integrated Naval Nuclear Energy Campus.
-
HDL Capital (formerly WD Capital Markets) Management Buyout
March 31, 2025
Financial Services
The leadership team of WD Capital Markets Inc. completed a management buyout, acquiring 100% of the company and relaunching it as HDL Capital Inc., effective March 31, 2025. HDL will continue providing M&A advisory and transaction services to small- and mid-market clients from its Toronto base and expects to expand its team and Transaction Services practice.
-
Healthcare AI Acquisition Corp. to Take Leading Group Public via Business Combination
August 15, 2024
Financial Services
Leading Group Limited, a China-based digital insurance broker and insurance channel specialist, entered into a definitive business combination agreement with Healthcare AI Acquisition Corp. (NASDAQ: HAIA). The deal will result in a series of merger transactions where Leading Group will be the surviving entity and the combined company is intended to be listed on Nasdaq.
-
Mana Capital Acquisition Corp. Completes Business Combination with Cardio Diagnostics (Cardio Diagnostics Holdings, Inc.)
October 26, 2022
Biotechnology
Mana Capital Acquisition Corp. completed its business combination with Cardio Diagnostics, resulting in Cardio Diagnostics Holdings, Inc. being listed on Nasdaq under ticker CDIO (common stock) and CDIOW (warrants). The deal had been supported by a previously announced definitive merger agreement dated May 27, 2022 and required multiple extensions to complete before closing.
-
Carousel Capital Recapitalizes Legacy Data Access with Cadrillion Capital
July 20, 2021
Healthcare Services
Carousel Capital has partnered with Cadrillion Capital to recapitalize Legacy Data Access, LLC, a Charlotte-based provider of healthcare data lifecycle management and legacy EHR/EMR archiving solutions. The recapitalization will provide capital to support LDA's growth and platform development, with Carousel funding the transaction from its sixth investment fund.
-
Hyperfine and Liminal Sciences to Combine via HealthCor Catalio SPAC Business Combination
July 8, 2021
Healthcare Services
Hyperfine and Liminal Sciences entered into a definitive business combination agreement with healthcare-focused SPAC HealthCor Catalio Acquisition Corp. Upon closing, HealthCor Catalio will be renamed as Hyperfine, and the combined company is expected to trade on Nasdaq under ticker HYPR. The transaction is valued at approximately $580 million enterprise value and includes a $126 million PIPE (with institutional participation). The companies expect the deal to close in the fourth quarter of 2021, subject to customary approvals and conditions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.